P1150: A PROSPECTIVE PHASE II CLINICAL TRIAL USING CHIDAMIDE, TISLELIZUMAB, AND PEGASPARGASE IN COMBINATION WITH RADIOTHERAPY AS FIRST-LINE TREATMENT IN STAGES I/II OF EXTRANODAL NK/T-CELL LYMPHOMA

• Hui Zhou,
• Yajun LI,
• Ruolan Zeng,
• Yizi He

Affiliations

Hui Zhou

1 Hunan Cancer Hospital, Department of Lymphoma and Hematology, Changsha, China

Yajun LI

1 Hunan Cancer Hospital, Department of Lymphoma and Hematology, Changsha, China

Ruolan Zeng

1 Hunan Cancer Hospital, Department of Lymphoma and Hematology, Changsha, China

Yizi He

1 Hunan Cancer Hospital, Department of Lymphoma and Hematology, Changsha, China